Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs

Pharmacogenetics and Genomics
Jason SalibaSharon E Plon

Abstract

Mutations or alterations in expression of the 5' nucleotidase gene family can lead to altered responses to treatment with nucleoside analogs. While investigating leukemia susceptibility genes, we discovered a very rare p.L254P NT5C1A missense variant in the substrate recognition motif. Given the paucity of cellular drug response data from the NT5C1A germline variation, we characterized p.L254P and eight rare variants of NT5C1A from genomic databases. Through lentiviral infection, we created HEK293 cell lines that stably overexpress wild-type NT5C1A, p.L254P, or eight NT5C1A variants reported in the National Heart Lung and Blood Institute Exome Variant Server (one truncating and seven missense). IC50 values were determined by cytotoxicity assays after exposure to chemotherapeutic nucleoside analogs (cladribine, gemcitabine, 5-fluorouracil). In addition, we used structure-based homology modeling to generate a three-dimensional model for the C-terminal region of NT5C1A. The p.R180X (truncating), p.A214T, and p.L254P missense changes were the only variants that significantly impaired protein function across all nucleotide analogs tested (>5-fold difference vs. wild-type; P<0.05). Several of the remaining variants individually showe...Continue Reading

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
Jan 11, 2000·Nucleic Acids Research·S T SherryK Sirotkin
Jan 13, 2001·The Journal of Biological Chemistry·S A HunsuckerB S Mitchell
Jul 27, 2002·The Lancet Oncology·Carlos M GalmariniCharles Dumontet
Sep 28, 2002·Nature Structural Biology·Agnes Rinaldo-MatthisPär Nordlund
Jun 21, 2005·Pharmacology & Therapeutics·Sally Anne HunsuckerJozef Spychala
Jun 28, 2005·Nucleic Acids Research·Johannes SödingAndrei N Lupas
Nov 18, 2005·Cancer Chemotherapy and Pharmacology·Terzah M HortonStacey L Berg
May 5, 2006·The Journal of Biological Chemistry·Eduard BittoGeorge N Phillips
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Dec 21, 2012·Pediatric Blood & Cancer·Bradford C PowellSharon E Plon
Feb 5, 2013·Nature Genetics·Julia A MeyerWilliam L Carroll
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
May 30, 2013·Genes, Chromosomes & Cancer·Reika IwakawaJun Yokota
Jan 31, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Oct 31, 2014·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Feb 7, 2015·Biochemical Pharmacology·F CividiniM G Tozzi

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
restriction digest
transfection

Software Mentioned

HHpred
R Statistical Software
Synergy
PyMOL Molecular Graphics System
Modeller
plyr
COOT
ggplot2
Kaleidagraph

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.